Skip to main content
. 2017 Mar 27;2017:2432957. doi: 10.1155/2017/2432957

Table 2.

Anthropometric and clinical characteristics of participating children in the study.

Factor Normal weight Overweight Obese p
719 (50.5%) 308 (21.6%) 396 (27.9%)
Gender n (%)
 Male 378 (52.6) 144 (46.8) 221 (55.8) 0.107a
 Female 341 (47.4) 164 (53.3) 175 (44.2)
Age (years) 9 (7–11) 9 (8–11) 9 (8–11) 0.066b
BMI (kg/m2) 16.4 (15.2–17.9) 20.3 (18.8–21.7) 24.1 (22–26.8) <0.001b
Waist circumference (cm) 57.6 (53.7–62.9) 68.1 (62.8–73.9) 78 (72.2–86.2) <0.001b
Abdominal obesity, n (%)
 No 694 (96.5) 191 (62) 31 (7.8) <0.001a
 Yes 35 (3.5) 117 (38) 365 (92.2)
SBP (mmHg) 95 (90–100) 100 (90–105) 100.5 (95–110) <0.001b
DBP (mmHg) 65 (60–70) 69 (60–70) 70 (60–73) <0.001b
Glucose (mg/dl) 81 (75–87) 82 (77–88) 83 (77–89) 0.007b
Cholesterol (mg/dl) 152 (132–175) 158 (137.5–177) 157.5 (136–181.5) 0.008b
HDL-c (mg/dl) 54 (45–61) 49.5 (41–57.5) 43 (37–52) <0.001b
LDL-c (mg/dl) 96 (82–114) 104.5 (88–120) 105.5 (89.5–122) <0.001b
Triglycerides (mg/dl) 70 (55–90) 87.5 (66.5–119.5) 103 (76–147.5) <0.001b
Adiponectin (μg/ml) 14.5 (12.5–16.4) 14.1 (12.3–16.5) 13.6 (11.8–16.0) 0.009b
Leptin (ng/ml) 10.2 (5.8–17.4) 22.4 (14.8–29.5) 30.9 (22.6–38.4) <0.001b
Insulin (μU/ml) 4.6 (2.6–7.4) 7.4 (4.3–11) 9.7 (4.8–16.2) <0.001b
HOMA-IR, n (%)
 <percentile 90 703 (97.7) 289 (93.8) 284 (71.7) <0.001a
 ≥percentile 90 16 (2.3) 19 (6.2) 112 (28.3)
Acanthosis, n (%)
 No 642 (89.3) 225 (73.1) 148 (37.4) <0.001a
 Yes 77 (10.7) 83 (26.9) 248 (62.6)
T2D family history, n (%)
 No 655 (91.1) 268 (87) 340 (85.9) 0.017a
 Yes 64 (8.9) 40 (13) 56 (14.1)
Obesity family history, n (%)
 No 390 (54.2) 139 (45.1) 137 (34.6) <0.001a
 Yes 329 (45.8) 169 (54.9) 259 (65.4)

Data are reported as medians (25th–75th) or as noted in table. aChi-square test; bKruskall Wallis test. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL-c: high density lipoprotein-cholesterol; LDL-c: low density lipoprotein-cholesterol; HOMA-IR: homeostatic model assessment-insulin resistance; T2D: type 2 diabetes.